Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedThe footer's site revision identifier changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study’s status changed from **Recruiting** to **Active, not recruiting**, and the page now indicates it is no longer looking for participants. A new record-history version dated 2026-11-03 was added, covering recruitment status, study status, study design, and contacts/locations.SummaryDifference0.7%

- Check29 days agoChange DetectedA notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears on the page. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check43 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check50 days agoChange DetectedThe record history now includes Eligibility and Study Status sections, and shows a change dated 2026-09-22 with 40 changes, while a prior entry dated 2026-08-20 was deleted.SummaryDifference0.3%

- Check64 days agoChange DetectedThe added entries include a lowercase 'Find contact information' label and a new 'Revision: v3.7.0' tag, while the previous uppercase 'Find Contact Information' and 'Revision: v3.6.6' entries are removed.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.